Tempest Therapeutics Appoints Two Independent Directors
Tempest Therapeutics (Nasdaq: TPST) announced the appointment of Drake Richey and John Yee, M.D., M....
Australia's Imugene Presents Azer-Cel Clinical Progress at ASCO
Imugene Ltd presented clinical progress on its Azer-Cel program at the American Society of Clinical ...
Hong Kong's Lok Ma Chau Loop Hong Kong Park Plans to Prioritize Funding for Shared CDMO and Clinical Trials
In 2026, the Hong Kong Park of the Lok Ma Chau Loop Shenzhen-Hong Kong Science and Technology Innova...
Mabwell's 9MW5211 Receives NMPA Clinical Trial Approval for IBD in China
Shanghai, June 4, 2026 — Mabwell (688062.SH, 02493.HK) announced that its independently developed in...
WuXi Biologics CRDMO Formulation Plant in Singapore Tops Out with Annual Capacity of 100 Million Units
WuXi Biologics (2269.HK) announced that its formulation plant at the Contract Research, Development ...
U.S. AI Anti-Aging Company NewLimit Completes $435 Million Series C Funding
U.S. biotech company NewLimit has completed a $435 million Series C funding round, achieving a post-...
Eli Lilly and Ascidian Partner in Over $1.9 Billion Deal to Develop RNA Editors for Genetic Kidney Disease
Eli Lilly has entered into a global research collaboration with Ascidian Therapeutics to jointly dev...
AstraZeneca liver cancer combination therapy reduces risk of progression or death by 30%
Results from AstraZeneca's Phase III Emerald-3 trial showed that the regimen of durvalumab combined ...
Genetically Modified Hookworms Turned into Drug Factories by Washington University School of Medicine in St. Louis
Researchers at Washington University School of Medicine in St. Louis have successfully genetically m...
Canada's NeuroThera Acquires 54% Stake in CliniQuantum for Approximately $9.45 Million
NeuroThera Labs Inc. (TSXV: NTLX) announced the completion of its acquisition of approximately 54.01...